218 studies found for: Open Studies | "Colitis, Ulcerative"
The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
|4||Not yet recruiting||
GSK2982772 Study in Ulcerative Colitis Patients
Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients
|6||Not yet recruiting||
Mercaptopurine Therapy in Ulcerative Colitis
Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative Colitis
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
|9||Not yet recruiting||
Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
|17||Not yet recruiting||
Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis
|18||Not yet recruiting||
Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
† Study has passed its completion date and status has not been verified in more than two years.